SCIB2, an antibody DNA vaccine encoding NY-ESO-1 epitopes, induces potent antitumor immunity which is further enhanced by checkpoint blockade
Checkpoint blockade has demonstrated promising antitumor responses in approximately 10-40% of patients. However, the majority of patients do not make a productive immune response to their tumors and do not respond to checkpoint blockade. These patients may benefit from an effective vaccine that stim...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Published: |
Taylor & Francis
2016
|
| Subjects: | |
| Online Access: | https://eprints.nottingham.ac.uk/49788/ |